Trung Huynh
Stock Analyst at UBS
(1.95)
# 1242
Out of 5,270 analysts
33
Total ratings
50.00%
Success rate
29.55%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Jasper Therapeutics | Initiates Coverage On: Buy | 38 | 5.72 | 564.34% | 1 | Feb 13, 2025 | |
Celldex Therapeutics | Initiates Coverage On: Buy | 44 | 19.86 | 121.55% | 1 | Feb 13, 2025 | |
Regeneron Pharmaceut... | Downgrades: Neutral | 1130 738 | 687.82 | 7.3% | 1 | Jan 16, 2025 | |
Kyverna Therapeutics | Initiates Coverage On: Buy | 13 | 2.62 | 396.18% | 1 | Oct 10, 2024 | |
Cabaletta Bio | Initiates Coverage On: Buy | 10 | 1.69 | 491.72% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 54 | 59.63 | -9.44% | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 78 84 | 77.23 | 8.77% | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Strong Buy | 612 710 | 927.19 | -23.42% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 170 175 | 166.34 | 5.21% | 2 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 220 200 | 309.49 | -35.38% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 47 40 | 26.02 | 53.73% | 4 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 126 | 92.7 | 35.92% | 3 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 170 | 211.25 | -19.53% | 1 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Mar 23, 2021 |